These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8682618)

  • 1. Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV.
    Kawanishi M
    Intervirology; 1995; 38(3-4):206-13. PubMed ID: 8682618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines.
    Gao X; Tajima M; Sairenji T
    Virology; 1999 Jun; 258(2):375-81. PubMed ID: 10366574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells.
    Gao X; Wang H; Sairenji T
    J Virol; 2004 Nov; 78(21):11798-806. PubMed ID: 15479821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition.
    Djeraba A; Bernardet N; Dambrine G; Quéré P
    Virology; 2000 Nov; 277(1):58-65. PubMed ID: 11062036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase I and II activities are required for Epstein-Barr virus replication.
    Kawanishi M
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2263-8. PubMed ID: 8409949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter.
    Lin JC; Smith MC; Pagano JS
    J Virol; 1983 Mar; 45(3):985-91. PubMed ID: 6300468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of human hepatocytes in culture to reactive nitrogen intermediates.
    D'Ambrosio SM; Oberyszyn TM; Brady T; Ross MS; Robertson FM
    Biochem Biophys Res Commun; 1997 Apr; 233(2):545-9. PubMed ID: 9144574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
    Tsurumi T
    Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
    Lin JC; Smith MC
    Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of neuropeptide Y1 receptor function in SK-N-MC cells by nitric oxide.
    Dötsch J; Hänze J; Beste O; Behrendt J; Weber WM; Dittrich K; Rascher W
    Am J Physiol; 1997 Aug; 273(2 Pt 1):C618-21. PubMed ID: 9277359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
    Lin JC; Smith MC; Pagano JS
    Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection.
    Kawanishi M
    J Virol; 1993 Dec; 67(12):7654-8. PubMed ID: 8230485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.